Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Sildenafil and erectile dysfunction.

× No keyword cloud information.

17 in total

Review 1. The role of nitric oxide in erectile function.

Authors: J A Lugg; N F González-Cadavid; J Rajfer
Journal: J Androl Date: 1995 Jan-Feb

2. Identification and characterization of a novel family of cyclic nucleotide phosphodiesterases.

Authors: S H Soderling; S J Bayuga; J A Beavo
Journal: J Biol Chem Date: 1998-06-19 Impact factor: 5.157

Review 3. Update on male erectile dysfunction.

Authors: G Wagner; I Saenz de Tejada
Journal: BMJ Date: 1998-02-28

Review 4. A therapeutic taxonomy of treatments for erectile dysfunction: an evolutionary imperative.

Authors: J P Heaton; M A Adams; A Morales
Journal: Int J Impot Res Date: 1997-09 Impact factor: 2.896

5. Effects of sildenafil on the relaxation of human corpus cavernosum tissue in vitro and on the activities of cyclic nucleotide phosphodiesterase isozymes.

Authors: S A Ballard; C J Gingell; K Tang; L A Turner; M E Price; A M Naylor
Journal: J Urol Date: 1998-06 Impact factor: 7.450

Review 6. NIH Consensus Conference. Impotence. NIH Consensus Development Panel on Impotence.

Authors:
Journal: JAMA Date: 1993-07-07 Impact factor: 56.272

7. Oral phentolamine as treatment for erectile dysfunction.

Authors: A J Becker; C G Stief; S Machtens; D Schultheiss; U Hartmann; M C Truss; U Jonas
Journal: J Urol Date: 1998-04 Impact factor: 7.450

8. Sildenafil, a type-5 CGMP phosphodiesterase inhibitor, specifically amplifies endogenous cGMP-dependent relaxation in rabbit corpus cavernosum smooth muscle in vitro.

Authors: A T Chuang; J D Strauss; R A Murphy; W D Steers
Journal: J Urol Date: 1998-07 Impact factor: 7.450

9. Sildenafil: an orally active type 5 cyclic GMP-specific phosphodiesterase inhibitor for the treatment of penile erectile dysfunction.

Authors: M Boolell; M J Allen; S A Ballard; S Gepi-Attee; G J Muirhead; A M Naylor; I H Osterloh; C Gingell
Journal: Int J Impot Res Date: 1996-06 Impact factor: 2.896

10. Clinical safety of oral sildenafil citrate (VIAGRA) in the treatment of erectile dysfunction.

Authors: A Morales; C Gingell; M Collins; P A Wicker; I H Osterloh
Journal: Int J Impot Res Date: 1998-06 Impact factor: 2.896

5 in total

1. Are subjects with erectile dysfunction aware of their condition? Results from a retrospective study based on an Italian free-call information service.

Authors: A Aversa; A M Isidori; D Gianfrilli; E A Greco; A Graziottin; G Zizzo; A Lenzi; A Fabbri
Journal: J Endocrinol Invest Date: 2004-06 Impact factor: 4.256

Review 5. Avanafil for erectile dysfunction in elderly and younger adults: differential pharmacology and clinical utility.

Authors: Eric G Katz; Ronny Bw Tan; Daniel Rittenberg; Wayne J Hellstrom
Journal: Ther Clin Risk Manag Date: 2014-08-27 Impact factor: 2.423